In this high-impact, field-based role, you will drive the adoption and growth of Signatera, Natera's personalized molecular residual disease (MRD) ctDNA assay, helping clinicians monitor cancer and inform treatment decisions throughout the patient journey. You will collaborate cross-functionally to expand access to Signatera while partnering with Radiation Oncologists, ENT/Otolaryngology physicians, Head & Neck Surgeons, Medical Oncologists, Pathologists, and other members of the multidisciplinary care team.